Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi ...

Strive Asset Management is going public through a reverse merger and will use the combined company’s stock to accumulate ...

Q1 2025 Earnings Call Transcript April 29, 2025 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0 ...

Colossal Biosciences, an American biotechnology company, announced the "de-extinction" of the dire wolf, a prehistoric wolf ...

The creation of three "dire wolf" pups has raised hopes that it may be possible to resurrect extinct animals. But some ...

Axsome beat Q1 expectations with $121.5 million in revenue and strong Auvelity sales as it prepares Symbravo's U.S. launch ...

Nautilus Biotechnology, Inc. ( NASDAQ: NAUT) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Ji-Yon Yi - Head, Investor Relations Sujal Patel - Co-Founder & Chief Executive Officer Parag ...

Plenty Richmond Farm is growing strawberries on 30-foot vertical towers using 97 percent less land and 90 percent less water ...

Selected in the bioprocessing category, Dr. Narain is honored for his pioneering work at the intersection of biology, AI, and translational medicine. Under his leadership, BPGbio has focused on ...

Going forward, PTS and Appspace are providing ongoing service and support, with a team ensuring the systems perform at peak ...

As you would probably expect from such a well-known name connected to the healthcare industry, the goals for GSK for this new ...

With this approval approximately 45 people[i] living with cystic fibrosis, many with a rare mutation, will be newly eligible for a medicine that ...